FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

CLAUDE LECLERC

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Physiology

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Xiaoming Zhang; Laleh Majlessi; Edith Deriaud; CLAUDE LECLERC; Richard Lo-Man
Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils.
Magali Terme; Grégoire Mignot; Evelyn Ullrich; Mathieu Bonmort; Véronique Minard-Colin; Alexandra Jacquet; Joachim L Schultze; Guido Kroemer; CLAUDE LECLERC; Nathalie Chaput; Laurence Zitvogel
The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
Sylvie Bay; Sébastien Fort; L Birikaki; C Ganneau; E Samain; Yves-Marie Coïc; François Bonhomme; Edith Dériaud; CLAUDE LECLERC; Richard Lo-Man
Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of CLAUDE LECLERC (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Xiaoming Zhang; Laleh Majlessi; Edith Deriaud; CLAUDE LECLERC; Richard Lo-Man
Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils.
Immunity 2009;31(5):761-71.
2009: Magali Terme; Grégoire Mignot; Evelyn Ullrich; Mathieu Bonmort; Véronique Minard-Colin; Alexandra Jacquet; Joachim L Schultze; Guido Kroemer; CLAUDE LECLERC; Nathalie Chaput; Laurence Zitvogel
The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
Cancer research 2009;69(16):6590-7.
2009: Sylvie Bay; Sébastien Fort; L Birikaki; C Ganneau; E Samain; Yves-Marie Coïc; François Bonhomme; Edith Dériaud; CLAUDE LECLERC; Richard Lo-Man
Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide.
ChemMedChem 2009;4(4):582-7.
2009: Edgar Badell; Fabienne Nicolle; Simon Clark; Laleh Majlessi; Frédéric Boudou; Angelo Martino; Luiz Castello-Branco; CLAUDE LECLERC; David J M Lewis; Philip D Marsh; Brigitte Gicquel; Nathalie Winter
Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
Vaccine 2009;27(1):28-37.
2008: Juliette Mouriès; Gabriel Moron; Géraldine Schlecht; Nicolas Escriou; Gilles Dadaglio; CLAUDE LECLERC
Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.
Blood 2008;112(9):3713-22.
2008: CLAUDE LECLERC; Claudia Brose; Clémence Nouzé; Fransisca Leonard; Laleh Majlessi; Sybille Becker; Hagen von Briesen; Richard Lo-Man
Immobilized cytokines as biomaterials for manufacturing immune cell based vaccines.
Journal of biomedical materials research. Part A 2008;86(4):1033-40.
2008: Laleh Majlessi; Richard Lo-Man; CLAUDE LECLERC
Regulatory B and T cells in infections.
Microbes and infection / Institut Pasteur 2008;10(9):1030-5.
2008: Grégory Doré; CLAUDE LECLERC; Françoise Lazarini
Treatment by CpG or Flt3-ligand does not affect mouse susceptibility to BSE prions.
Journal of neuroimmunology 2008;197(1):74-80.
2008: Wafa Frigui; Daria Bottai; Laleh Majlessi; Marc Monot; Emmanuelle Josselin; Priscille Brodin; Thierry Garnier; Brigitte Gicquel; Carlos Martin; CLAUDE LECLERC; Stewart T Cole; Roland Brosch
Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP.
PLoS pathogens 2008;4(2):e33.
2008: Barbara Jaron; Eddie Maranghi; CLAUDE LECLERC; Laleh Majlessi
Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis.
PloS one 2008;3(7):e2833.
2007: Pedro Berraondo; Clémence Nouzé; Xavier Préville; Daniel Ladant; CLAUDE LECLERC
Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system.
Cancer research 2007;67(18):8847-55.
2007: Laleh Majlessi; Benoit Combaluzier; Imke Albrecht; Jessica E Garcia; Clémence Nouze; Jean Pieters; CLAUDE LECLERC
Inhibition of phagosome maturation by mycobacteria does not interfere with presentation of mycobacterial antigens by MHC molecules.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(3):1825-33.
2007: Tom G Connell; Muki S Shey; Ronnett Seldon; Molebogeng X Rangaka; Gilles Van Cutsem; Marcela Simsova; Zuzana Marcekova; Peter Sebo; Nigel Curtis; Lavanya Diwakar; Graeme Meintjes; CLAUDE LECLERC; Robert J Wilkinson; Katalin A Wilkinson
Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector.
Clinical and vaccine immunology : CVI 2007;14(7):847-54.
2007: Sandra Hervas-Stubbs; Aurélie Olivier; Florence Boisgerault; Nathalie Thieblemont; CLAUDE LECLERC
TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help.
Blood 2007;109(12):5318-26.
2007: Xiaoming Zhang; Edith Deriaud; Xinan Jiao; Deborah Braun; CLAUDE LECLERC; Richard Lo-Man
Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells.
The Journal of experimental medicine 2007;204(5):1107-18.
2007: CLAUDE LECLERC
[New technologies for vaccine development].
Médecine sciences : M/S 2007;23(4):386-90.
2007: Sandra Hervas-Stubbs; Paloma Rueda; Lissette Lopez; CLAUDE LECLERC
Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(4):2361-9.
2007: Juan José Lasarte; Noelia Casares; Marta Gorraiz; Sandra Hervás-Stubbs; Laura Arribillaga; Cristina Mansilla; Maika Durantez; Diana Llopiz; Pablo Sarobe; Francisco Borrás-Cuesta; Jesús Prieto; CLAUDE LECLERC
The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(2):748-56.
2006: Teresa Freire; Sylvie Bay; Sophie Vichier-Guerre; Richard Lo-Man; CLAUDE LECLERC
Carbohydrate antigens: synthesis aspects and immunological applications in cancer.
Mini reviews in medicinal chemistry 2006;6(12):1357-73.
2006: Zhi-Ming Pan; Xiao-Ming Zhang; Xin-an Jiao; Richard Lo-Man; CLAUDE LECLERC; Xiu-fan Liu
[Analysis of in vitro delivering CD8+ T epitopes by attenuated bacteria].
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 2006;22(6):730-3.
2006: Julien Y Bertrand; Guillaume E Desanti; Richard Lo-Man; CLAUDE LECLERC; Ana Cumano; Rachel Golub
Fetal spleen stroma drives macrophage commitment.
Development (Cambridge, England) 2006;133(18):3619-28.
2006: Sandra Hervas-Stubbs; Laleh Majlessi; Marcela Simsova; Jana Morova; Marion Rojas; Clémence Nouzé; Priscille Brodin; Peter Sebo; CLAUDE LECLERC
High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
Infection and immunity 2006;74(6):3396-407.
2006: Catherine Rybner-Barnier; Catherine Jacquemot; Céline Cuche; Grégory Doré; Laleh Majlessi; Marie-Madeleine Gabellec; Arnaud Moris; Olivier Schwartz; James Di Santo; Ana Cumano; CLAUDE LECLERC; Françoise Lazarini
Processing of the bovine spongiform encephalopathy-specific prion protein by dendritic cells.
Journal of virology 2006;80(10):4656-63.
2006: Teresa Freire; Richard Lo-Man; Friedrich Piller; Véronique Piller; CLAUDE LECLERC; Sylvie Bay
Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.
Glycobiology 2006;16(5):390-401.
2006: Laurent MASCARELL; Cecile Bauche; Catherine Fayolle; Ousmane M Diop; Monique Dupuy; Nolwenn Nougarede; Ronald Perraut; Daniel Ladant; CLAUDE LECLERC
Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates.
Vaccine 2006;24(17):3490-9.
2006: Laleh Majlessi; Marcela Simsova; Zdenka Jarvis; Priscille Brodin; Marion Rojas; Cecile Bauche; Clémence Nouzé; Daniel Ladant; Stewart T Cole; Peter Sebo; CLAUDE LECLERC
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
Infection and immunity 2006;74(4):2128-37.
2006: Géraldine Schlecht; Juliette Mouriès; Maud Poitrasson-Rivière; CLAUDE LECLERC; Gilles Dadaglio
Purification of splenic dendritic cells induces maturation and capacity to stimulate Th1 response in vivo.
International immunology 2006;18(3):445-52.
2006: Priscille Brodin; Laleh Majlessi; Laurent Marsollier; Marien I de Jonge; Daria Bottai; Caroline Demangel; Jason Hinds; Olivier Neyrolles; Philip Butcher; CLAUDE LECLERC; Stewart T Cole; Roland Brosch
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence.
Infection and immunity 2006;74(1):88-98.
2005: Priscille Brodin; Marien I de Jonge; Laleh Majlessi; CLAUDE LECLERC; Michael Nilges; Stewart T Cole; Roland Brosch
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity.
The Journal of biological chemistry 2005;280(40):33953-9.
2005: Jiri Masin; Marek Basler; Oliver Knapp; Mohammed El-Azami-El-Idrissi; Elke Maier; Ivo Konopasek; Roland Benz; CLAUDE LECLERC; Peter Sebo
Acylation of lysine 860 allows tight binding and cytotoxicity of Bordetella adenylate cyclase on CD11b-expressing cells.
Biochemistry 2005;44(38):12759-66.
2005: Saulius Grigalevicius; Sabine Chierici; Olivier Renaudet; Richard Lo-Man; Edith Dériaud; CLAUDE LECLERC; Pascal DUMY
Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
Bioconjugate chemistry 2005;16(5):1149-59.
2005: Laurent MASCARELL; Catherine Fayolle; Cecile Bauche; Daniel Ladant; CLAUDE LECLERC
Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
Journal of virology 2005;79(15):9872-84.
2005: Katalin A Wilkinson; Marcela Simsova; Elisabeth Schölvinck; Peter Sebo; CLAUDE LECLERC; Martin Vordermeier; Stuart J Dickson; Jillian R Brown; Robert N Davidson; Geoffrey Pasvol; Michael Levin; Robert J Wilkinson
Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids.
Infection and immunity 2005;73(5):2991-8.
2005: Cheng-Ming Sun; Edith Deriaud; CLAUDE LECLERC; Richard Lo-Man
Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs.
Immunity 2005;22(4):467-77.
2005: Laleh Majlessi; Priscille Brodin; Roland Brosch; Marion Rojas; Huot Khun; Michel Huerre; Stewart T Cole; CLAUDE LECLERC
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3570-9.
2005: Florence Boisgérault; Paloma Rueda; Cheng-Ming Sun; Sandra Hervas-Stubbs; Marie Rojas; CLAUDE LECLERC
Cross-priming of T cell responses by synthetic microspheres carrying a CD8+ T cell epitope requires an adjuvant signal.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3432-9.
2005: Xavier Préville; Daniel Ladant; Benedikt Timmerman; CLAUDE LECLERC
Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.
Cancer research 2005;65(2):641-9.
2004: Catherine Fayolle; Cecile Bauche; Daniel Ladant; CLAUDE LECLERC
Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
Vaccine 2004;23(5):604-14.
2004: Géraldine Schlecht; Jirina Loucka; Hossain Najar; Peter Sebo; CLAUDE LECLERC
Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(10):6089-97.
2004: Martin Vordermeier; Marcela Simsova; Katalin A Wilkinson; Robert J Wilkinson; R Glyn Hewinson; Peter Sebo; CLAUDE LECLERC
Recognition of mycobacterial antigens delivered by genetically detoxified Bordetella pertussis adenylate cyclase by T cells from cattle with bovine tuberculosis.
Infection and immunity 2004;72(11):6255-61.
2004: Géraldine Schlecht; Sylvie Garcia; Nicolas Escriou; Antonio A Freitas; CLAUDE LECLERC; Gilles Dadaglio
Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation.
Blood 2004;104(6):1808-15.
2004: Matthias Regner; Xavier Martinez; Elodie Belnoue; Cheng-Ming Sun; Florence Boisgerault; Paul-Henri Lambert; CLAUDE LECLERC; Claire-Anne Siegrist
Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheres.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(4):2669-74.
2004: Richard Lo-Man; Sophie Vichier-Guerre; Ronald Perraut; Edith Dériaud; Valérie Huteau; Lbachir BenMohamed; Ousmane M Diop; Philip O Livingston; Sylvie Bay; CLAUDE LECLERC
A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.
Cancer research 2004;64(14):4987-94.
2004: Sophie Vichier-Guerre; Richard Lo-Man; Valérie Huteau; Edith Dériaud; CLAUDE LECLERC; Sylvie Bay
Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.
Bioorganic & medicinal chemistry letters 2004;14(13):3567-70.
2004: Priscille Brodin; Laleh Majlessi; Roland Brosch; Debbie Smith; Gregory Bancroft; Simon Clark; Ann Williams; CLAUDE LECLERC; Stewart T Cole
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
The Journal of infectious diseases 2004;190(1):115-22.
2004: Marcela Simsova; Peter Sebo; CLAUDE LECLERC
The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.
International journal of medical microbiology : IJMM 2004;293(7-8):571-6.
2004: Caroline Demangel; Priscille Brodin; Paul J Cockle; Roland Brosch; Laleh Majlessi; CLAUDE LECLERC; Stewart T Cole
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6.
Infection and immunity 2004;72(4):2170-6.
2004: Paloma Rueda; Gabriel Morón; J Sarraseca; CLAUDE LECLERC; J Ignacio Casal
Influence of flanking sequences on presentation efficiency of a CD8+ cytotoxic T-cell epitope delivered by parvovirus-like particles.
The Journal of general virology 2004;85(Pt 3):563-72.
2004: Gabriel Morón; Gilles Dadaglio; CLAUDE LECLERC
New tools for antigen delivery to the MHC class I pathway.
Trends in immunology 2004;25(2):92-7.
2003: Gilles Dadaglio; Sandra Morel; Cecile Bauche; Zhora Moukrim; François A Lemonnier; Benoît J Van den Eynde; Daniel Ladant; CLAUDE LECLERC
Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
International immunology 2003;15(12):1423-30.
2003: Laleh Majlessi; Marion Rojas; Priscille Brodin; CLAUDE LECLERC
CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family.
Infection and immunity 2003;71(12):7173-7.
2003: Mohammed El-Azami-El-Idrissi; Cecile Bauche; Jirina Loucka; Radim Osicka; Peter Sebo; Daniel Ladant; CLAUDE LECLERC
Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: Role of toxin acylation and identification of the main integrin interaction domain.
The Journal of biological chemistry 2003;278(40):38514-21.
2003: CLAUDE LECLERC
New approaches in vaccine development.
Comparative immunology, microbiology and infectious diseases 2003;26(5-6):329-41.
2003: Víctor Gabriel Morón; Paloma Rueda; Christine Sedlik; CLAUDE LECLERC
In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(5):2242-50.
2003: Sophie Vichier-Guerre; Richard Lo-Man; Lbachir BenMohamed; Edith Dériaud; S Kovats; CLAUDE LECLERC; Sylvie Bay
Induction of carbohydrate-specific antibodies in HLA-DR transgenic mice by a synthetic glycopeptide: a potential anti cancer vaccine for human use.
The journal of peptide research : official journal of the American Peptide Society 2003;62(3):117-24.
2003: Cheng-Ming Sun; Laurence Fiette; Myriam Tanguy; CLAUDE LECLERC; Richard Lo-Man
Ontogeny and innate properties of neonatal dendritic cells.
Blood 2003;102(2):585-91.
2003: Alexander S Pym; Priscille Brodin; Laleh Majlessi; Roland Brosch; Caroline Demangel; Ann Williams; Karen E Griffiths; Gilles Marchal; CLAUDE LECLERC; Stewart T Cole
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.
Nature medicine 2003;9(5):533-9.
2003: Xinan Jiao; Richard Lo-Man; Nathalie Winter; Edith Dériaud; Brigitte Gicquel; CLAUDE LECLERC
The shift of Th1 to Th2 immunodominance associated with the chronicity of Mycobacterium bovis bacille Calmette-Guérin infection does not affect the memory response.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(3):1392-8.
2003: Xavier Martinez; Matthias Regner; Jiri Kovarik; Shohreh Zarei; Conrad Hauser; Paul-Henri Lambert; CLAUDE LECLERC; Claire-Anne Siegrist
CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles.
Virology 2003;305(2):428-35.
2002: Mohammed El-Azami-El-Idrissi; Daniel Ladant; CLAUDE LECLERC
The adenylate cyclase of Bordetella pertussis: a vector to target antigen presenting cells.
Toxicon : official journal of the International Society on Toxinology 2002;40(12):1661-5.
2002: Pierre Guermonprez; Catherine Fayolle; Marion Rojas; Maria Rescigno; Daniel Ladant; CLAUDE LECLERC
In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells.
European journal of immunology 2002;32(11):3071-81.
2002: Mrinal K Ghosh; Cui-Ling Li; Catherine Fayolle; Gilles Dadaglio; Aileen Murphy; François A Lemonnier; Polly Roy; CLAUDE LECLERC
Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes.
Vaccine 2002;20(19-20):2463-73.
2002: Florence Boisgérault; Gabriel Morón; CLAUDE LECLERC
Virus-like particles: a new family of delivery systems.
Expert review of vaccines 2002;1(1):101-9.
2002: Gabriel Morón; Paloma Rueda; Ignacio Casal; CLAUDE LECLERC
CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.
The Journal of experimental medicine 2002;195(10):1233-45.
2002: Gilles Dadaglio; Cheng-Ming Sun; Richard Lo-Man; Claire-Anne Siegrist; CLAUDE LECLERC
Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(5):2219-24.
2002: Xinan Jiao; Richard Lo-Man; Pierre Guermonprez; Laurence Fiette; Edith Dériaud; Sophie Burgaud; Brigitte Gicquel; Nathalie Winter; CLAUDE LECLERC
Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(3):1294-301.
2002: Jiina Loucká; Géraldine Schlecht; Jana Vodolánová; CLAUDE LECLERC; Peter Sebo
Delivery of a MalE CD4(+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase.
Infection and immunity 2002;70(2):1002-5.
2002: Mrinal K Ghosh; Edith Dériaud; Marie-Françoise Saron; Richard Lo-Man; Thomas Henry; Xinan Jiao; Polly Roy; CLAUDE LECLERC
Induction of protective antiviral cytotoxic T cells by a tubular structure capable of carrying large foreign sequences.
Vaccine 2002;20(9-10):1369-77.
2001: Géraldine Schlecht; CLAUDE LECLERC; Gilles Dadaglio
Induction of CTL and nonpolarized Th cell responses by CD8alpha(+) and CD8alpha(-) dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(8):4215-21.
2001: Catherine Fayolle; A Osickova; Radim Osicka; T Henry; Marion Rojas; Marie-Françoise Saron; Peter Sebo; CLAUDE LECLERC
Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.
Journal of virology 2001;75(16):7330-8.
2001: Pierre Guermonprez; Nadia Khelef; Eric Blouin; Philippe Rieu; P Ricciardi-Castagnoli; Nicole Guiso; Daniel Ladant; CLAUDE LECLERC
The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18).
The Journal of experimental medicine 2001;193(9):1035-44.
2001: Richard Lo-Man; Sophie Vichier-Guerre; Sylvie Bay; Edith Dériaud; D Cantacuzène; CLAUDE LECLERC
Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(4):2849-54.
2000: E Coëffier; JM Clément; V Cussac; N Khodaei-Boorane; M Jehanno; Marie Rojas; A Dridi; M Latour; R El Habib; Françoise Barré-Sinoussi; Maurice Hofnung; CLAUDE LECLERC
Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein.
Vaccine 2000;19(7-8):684-93.
2000: Gilles Dadaglio; Zhora Moukrim; Richard Lo-Man; Valeria Sheshko; Peter Sebo; CLAUDE LECLERC
Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.
Infection and immunity 2000;68(7):3867-72.
2000: Christine Sedlik; Gilles Dadaglio; Marie-Françoise Saron; Edith Deriaud; Marie Rojas; S I Casal; CLAUDE LECLERC
In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.
Journal of virology 2000;74(13):5769-75.
2000: Richard Lo-Man; J P Langeveld; Edith Dériaud; M Jehanno; Marie Rojas; JM Clément; R H Meloen; Maurice Hofnung; CLAUDE LECLERC
Extending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar typhimurium delivery vehicle.
Infection and immunity 2000;68(6):3079-89.
2000: H Himmelrich; Richard Lo-Man; Nathalie Winter; Pierre Guermonprez; Christine Sedlik; Marie Rojas; D Monnaie; M Gheorghiu; Micheline Lagranderie; Maurice Hofnung; Brigitte Gicquel; JM Clément; CLAUDE LECLERC
Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: malE.
Vaccine 2000;18(24):2636-47.
2000: Sophie Vichier-Guerre; Richard Lo-Man; Sylvie Bay; Edith Deriaud; Hiroshi Nakada; CLAUDE LECLERC; D Cantacuzène
Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen.
The journal of peptide research : official journal of the American Peptide Society 2000;55(2):173-80.
2000: Pierre Guermonprez; Catherine Fayolle; Gouzel Karimova; Agnes Ullmann; CLAUDE LECLERC; Daniel Ladant
Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells.
Methods in enzymology 2000;326():527-42.
2000: Radim Osicka; A Osicková; T Basar; P Guermonprez; M Rojas; CLAUDE LECLERC; Peter Sebo
Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites.
Infection and immunity 2000;68(1):247-56.
1999: Pierre Guermonprez; Richard Lo-Man; Christine Sedlik; Marion Rojas; Roberto Poljak; CLAUDE LECLERC
mAb against hen egg-white lysozyme regulate its presentation to CD4(+) T cells.
International immunology 1999;11(11):1863-72.
1999: Peter Sebo; Zhora Moukrim; M Kalhous; N Schaft; Gilles Dadaglio; Valeria Sheshko; Catherine Fayolle; CLAUDE LECLERC
In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying multiple copies of a viral CD8(+) T-cell epitope.
FEMS immunology and medical microbiology 1999;26(2):167-73.
1999: Paloma Rueda; A Hurtado; M del Barrio; Jorge Luis Martínez-Torrecuadrada; Søren Kamstrup; CLAUDE LECLERC; J Ignacio Casal
Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles.
Virology 1999;263(1):89-99.
1999: Paloma Rueda; Jorge Luis Martínez-Torrecuadrada; J Sarraseca; Christine Sedlik; M del Barrio; A Hurtado; CLAUDE LECLERC; J Ignacio Casal
Engineering parvovirus-like particles for the induction of B-cell, CD4(+) and CTL responses.
Vaccine 1999;18(3-4):325-32.
1999: Catherine Fayolle; Daniel Ladant; Gouzel Karimova; Agnes Ullmann; CLAUDE LECLERC
Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(7):4157-62.
1999: Richard Lo-Man; Sylvie Bay; Sophie Vichier-Guerre; Edith Dériaud; D Cantacuzène; CLAUDE LECLERC
A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.
Cancer research 1999;59(7):1520-4.
1999: Christine Sedlik; A Dridi; Edith Deriaud; Marie-Françoise Saron; Paloma Rueda; J Sarraseca; J Ignacio Casal; CLAUDE LECLERC
Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T-cell and neutralizing antibody responses.
Journal of virology 1999;73(4):2739-44.
1999: Pierre Guermonprez; Daniel Ladant; Gouzel Karimova; Agnes Ullmann; CLAUDE LECLERC
Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(4):1910-6.
1999: J Wang; Valérie Michel; CLAUDE LECLERC; Maurice Hofnung; alain charbit
Immunogenicity of viral B-cell epitopes inserted into two surface loops of the Escherichia coli K12 LamB protein and expressed in an attenuated aroA strain of Salmonella typhimurium.
Vaccine 1999;17(1):1-12.
1998: Pierre Guermonprez; Patrick England; Hugues BEDOUELLE; CLAUDE LECLERC
The rate of dissociation between antibody and antigen determines the efficiency of antibody-mediated antigen presentation to T cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(9):4542-8.
1998: Gouzel Karimova; Catherine Fayolle; S Gmira; Agnes Ullmann; CLAUDE LECLERC; Daniel Ladant
Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(21):12532-7.
1998: E Coëffier; M Girard; Françoise Barré-Sinoussi; B Meignier; E Muchmore; PN Fultz; CLAUDE LECLERC
Fine specificity of anti-V3 antibodies induced in chimpanzees by HIV candidate vaccines.
AIDS research and human retroviruses 1998;14(12):1023-34.
1998: Christine Sedlik; Marie Rojas; CLAUDE LECLERC
Activation of B cells by 1 microm particulate lysozyme or peptides: a Th-dependent pathway requiring CD40-CD40 ligand interaction.
International immunology 1998;10(8):1111-9.
1998: CLAUDE LECLERC; J Ronco
New approaches in vaccine development.
Immunology today 1998;19(7):300-2.
1998: Richard Lo-Man; Paloma Rueda; Christine Sedlik; Edith Deriaud; Ignacio Casal; CLAUDE LECLERC
A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Th1 immune response without adjuvant.
European journal of immunology 1998;28(4):1401-7.
1998: Richard Lo-Man; J P Langeveld; P Martineau; Maurice Hofnung; R H Meloen; CLAUDE LECLERC
Immunodominance does not result from peptide competition for MHC class II presentation.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):1759-66.
1998: I Emery; CLAUDE LECLERC; K Sengphommachanh; Dominique A Vuitton; Martine Liance
In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis.
Parasite immunology 1998;20(2):81-91.
1997: E Coëffier; Jean-Louis Excler; Marie Paule Kieny; B Meignier; C Moste; Jim Tartaglia; Gilles Pialoux; Dominique Salmon-Céron; CLAUDE LECLERC
Restricted specificity of anti-V3 antibodies induced in humans by HIV candidate vaccines.
AIDS research and human retroviruses 1997;13(17):1471-85.
1997: I Emery; Martine Liance; CLAUDE LECLERC
Secondary Echinococcus multilocularis infection in A/J mice: delayed metacestode development is associated with Th1 cytokine production.
Parasite immunology 1997;19(11):493-503.
1997: I Emery; CLAUDE LECLERC; René Houin; Dominique A Vuitton; Martine Liance
Lack of H-2 gene influence on mouse susceptibility to secondary alveolar echinococcosis.
International journal for parasitology 1997;27(11):1433-6.
1997: Jean Claude Sirard; Catherine Fayolle; C de Chastellier; Michèle Mock; CLAUDE LECLERC; Patrick Berche
Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(9):4435-43.
1997: CLAUDE LECLERC; Edith Dériaud; Marie Rojas; Robert Whalen
The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA.
Cellular immunology 1997;179(2):97-106.
1997: Micheline Lagranderie; Richard Lo-Man; Edith Dériaud; Brigitte Gicquel; M Gheorghiu; CLAUDE LECLERC
Genetic control of antibody responses induced by recombinant Mycobacterium bovis BCG expressing a foreign antigen.
Infection and immunity 1997;65(8):3057-64.
1997: Christine Sedlik; Marie-Françoise Saron; J Sarraseca; Ignacio Casal; CLAUDE LECLERC
Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(14):7503-8.
1997: Sylvie Bay; Richard Lo-Man; Eduardo Osinaga; Hiroshi Nakada; CLAUDE LECLERC; D Cantacuzène
Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. A possible approach to a synthetic carbohydrate vaccine.
The journal of peptide research : official journal of the American Peptide Society 1997;49(6):620-5.
1997: CLAUDE LECLERC; P Martineau; B Charlot; Francis Delpeyroux; Sylvie van der Werf; Maurice Hofnung
Control by Ig genes of the responsiveness to a neutralization viral B cell epitope.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(7):3252-8.
1997: Marie-Françoise Saron; Catherine Fayolle; Peter Sebo; Daniel Ladant; Agnes Ullmann; CLAUDE LECLERC
Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(7):3314-9.
1997: alain charbit; Salete Newton; Phillip E Klebba; JM Clément; Catherine Fayolle; Richard Lo-Man; CLAUDE LECLERC; Maurice Hofnung
Expression and immune response to foreign epitopes in bacteria. Perspectives for live vaccine development.
Behring Institute Mitteilungen 1997;(98):135-42.
1997: Christine Sedlik; Edith Dériaud; CLAUDE LECLERC
Lack of Th1 or Th2 polarization of CD4+ T cell response induced by particulate antigen targeted to phagocytic cells.
International immunology 1997;9(1):91-103.
1996: P Martineau; CLAUDE LECLERC; Maurice Hofnung
Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein.
Molecular immunology 1996;33(17-18):1345-58.
1996: Richard Lo-Man; P Martineau; Edith Dériaud; Salete Newton; M Jehanno; Jean-Marie Clément; Catherine Fayolle; Maurice Hofnung; CLAUDE LECLERC
Control by H-2 genes of the Th1 response induced against a foreign antigen expressed by attenuated Salmonella typhimurium.
Infection and immunity 1996;64(11):4424-32.
1996: Richard Lo-Man; P Martineau; Maurice Hofnung; CLAUDE LECLERC
Homogeneous processing and presentation of a recombined T cell epitope in inbred mice of different non-MHC genetic background.
Cellular immunology 1996;172(2):180-91.
1996: Catherine Fayolle; U M Abdel-Motal; L Berg; Edith Deriaud; Mikael Jondal; CLAUDE LECLERC
Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help.
Immunology 1996;89(1):41-5.
1996: Richard Lo-Man; P Martineau; B Manoury-Schwartz; Maurice Hofnung; CLAUDE LECLERC
Overcoming the crypticity of a viral T cell determinant by insertion into a chimeric bacterial protein.
International immunology 1996;8(8):1245-55.
1996: Catherine Fayolle; Peter Sebo; Daniel Ladant; Agnes Ullmann; CLAUDE LECLERC
In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(12):4697-706.
1996: Christine Sedlik; Ronald Perraut; B Bonnemains; CLAUDE LECLERC
Antigens linked to synthetic microspheres induce immune responses in primates in the absence of adjuvant.
Immunobiology 1996;195(1):105-18.
1996: Micheline Lagranderie; Anne-Marie Balazuc; Edith Deriaud; CLAUDE LECLERC; M Gheorghiu
Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.
Infection and immunity 1996;64(1):1-9.
1995: Robert Whalen; CLAUDE LECLERC; Edith Dériaud; R Schirmbeck; J Reimann; Heather L Davis
DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
Annals of the New York Academy of Sciences 1995;772():64-76.
1995: Peter Sebo; Catherine Fayolle; O d'Andria; Daniel Ladant; CLAUDE LECLERC; Agnes Ullmann
Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells.
Infection and immunity 1995;63(10):3851-7.
1995: CLAUDE LECLERC; Christine Sedlik; Richard Lo-Man; B Charlot; Marie Rojas; Edith Dériaud
Stimulation of a memory B cell response does not require primed helper T cells.
European journal of immunology 1995;25(9):2533-8.
1995: Christine Sedlik; J Sarraseca; Paloma Rueda; CLAUDE LECLERC; I Casal
Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles.
The Journal of general virology 1995;76 ( Pt 9)():2361-8.
1995: N Escriou; CLAUDE LECLERC; S Gerbard; M Giraud; Sylvie van der Werf
Cytotoxic T cell response to Mengo virus in mice: effector cell phenotype and target proteins.
The Journal of general virology 1995;76 ( Pt 8)():1999-2007.
1995: Nathalie Winter; Micheline Lagranderie; S Gangloff; CLAUDE LECLERC; M Gheorghiu; Brigitte Gicquel
Recombinant BCG strains expressing the SIVmac251nef gene induce proliferative and CTL responses against nef synthetic peptides in mice.
Vaccine 1995;13(5):471-8.
1995: C Gengoux; CLAUDE LECLERC
In vivo induction of CD4+ T cell responses by antigens covalently linked to synthetic microspheres does not require adjuvant.
International immunology 1995;7(1):45-53.
1994: N Castignolles; D Betbeder; K Ioualalen; O Merten; CLAUDE LECLERC; D Samain; Pierre Perrin
Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors.
Vaccine 1994;12(15):1413-8.
1994: Catherine Fayolle; D O'Callaghan; P Martineau; alain charbit; Jean-Marie Clément; Maurice Hofnung; CLAUDE LECLERC
Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium.
Infection and immunity 1994;62(10):4310-9.
1994: M Gheorghiu; Micheline Lagranderie; Brigitte Gicquel; CLAUDE LECLERC
Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by recombinant BCG expressing a foreign antigen.
Infection and immunity 1994;62(10):4287-95.
1994: Richard Lo-Man; P Martineau; Jean-Michel Betton; Maurice Hofnung; CLAUDE LECLERC
Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(12):5660-9.
1994: CLAUDE LECLERC; Richard Lo-Man; Catherine Fayolle; alain charbit; Jean-Marie Clément; P Martineau; D O'Callaghan; Maurice Hofnung
Molecular and cellular parameters controlling the immunogenicity of foreign B- or T-cell epitopes expressed by recombinant vectors.
Developments in biological standardization 1994;82():193-9.
1994: CLAUDE LECLERC; Richard Lo-Man; alain charbit; P Martineau; Jean-Marie Clément; Maurice Hofnung
Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins.
International reviews of immunology 1994;11(2):123-32.
1993: CLAUDE LECLERC; P Martineau; alain charbit; Richard Lo-Man; Edith Dériaud; Maurice Hofnung
Immunodominance of a recombinant T-cell epitope depends on its molecular environment.
Molecular immunology 1993;30(17):1561-72.
1993: Richard Lo-Man; P Martineau; Maurice Hofnung; CLAUDE LECLERC
Induction of T cell responses by chimeric bacterial proteins expressing several copies of a viral T cell epitope.
European journal of immunology 1993;23(11):2998-3002.
1993: Micheline Lagranderie; A Murray; Brigitte Gicquel; CLAUDE LECLERC; M Gheorghiu
Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen.
Vaccine 1993;11(13):1283-90.
1993: alain charbit; P Martineau; J Ronco; CLAUDE LECLERC; Richard Lo-Man; Valérie Michel; D O'Callaghan; Maurice Hofnung
Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins.
Vaccine 1993;11(12):1221-8.
1993: A Galelli; B Charlot; Edith Dériaud; CLAUDE LECLERC
B cells do not present antigen covalently linked to microspheres.
Immunology 1993;79(1):69-76.
1993: CLAUDE LECLERC; Edith Dériaud; F Megret; Jean-Paul Briand; Marc H V van Regenmortel; Vincent Deubel
Identification of helper T cell epitopes of dengue virus E-protein.
Molecular immunology 1993;30(7):613-25.
1993: D O'Callaghan; P Martineau; Catherine Fayolle; CLAUDE LECLERC; J G Guillet; alain charbit; Maurice Hofnung
Immune responses to hybrid maltose-binding proteins.
Vaccine 1993;11(2):140-2.
1992: A Murray; Nathalie Winter; Micheline Lagranderie; D F Hill; Jean Rauzier; J Timm; CLAUDE LECLERC; K M Moriarty; M Gheorghiu; Brigitte Gicquel
Expression of Escherichia coli beta-galactosidase in Mycobacterium bovis BCG using an expression system isolated from Mycobacterium paratuberculosis which induced humoral and cellular immune responses.
Molecular microbiology 1992;6(22):3331-42.
1992: P Martineau; J G Guillet; CLAUDE LECLERC; Maurice Hofnung
Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes.
Gene 1992;118(1):151.
1992: Jean-Marie Clément; alain charbit; CLAUDE LECLERC; P Martineau; S Muir; D O'Callaghan; O Popescu; S Szmelcman; Maurice Hofnung
Molecular and cellular targeting in the expression of foreign polypeptides in bacteria.
Antonie van Leeuwenhoek 1992;61(2):143-52.
1992: M P Schutze; Pierre Langlade-Demoyen; CLAUDE LECLERC
Alloantigen-specific regulation of cytotoxic T cell responses is mediated through the induction of clonal anergy of CD8+ T cells.
European journal of immunology 1992;22(2):387-92.
1991: Nathalie Winter; Micheline Lagranderie; Jean Rauzier; J Timm; CLAUDE LECLERC; B Guy; Marie Paule Kieny; M Gheorghiu; Brigitte Gicquel
Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein.
Gene 1991;109(1):47-54.
1991: Catherine Fayolle; Edith Deriaud; CLAUDE LECLERC
In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(12):4069-73.
1991: CLAUDE LECLERC; alain charbit; P Martineau; Edith Deriaud; Maurice Hofnung
The cellular location of a foreign B cell epitope expressed by recombinant bacteria determines its T cell-independent or T cell-dependent characteristics.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(10):3545-52.
1991: Pierre Perrin; M L Joffret; C Zanetti; Hervé Bourhy; C Gontier; C Fritzell; CLAUDE LECLERC; P Sureau
Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccinees.
Vaccine 1991;9(8):549-58.
1991: Dominique Rueff-Juy; I Liberman; Anne-Marie Drapier; J C Guillon; CLAUDE LECLERC; Pierre-André Cazenave
Cellular basis of the resistance of newborn mice to the pathogenic effects of anti-CD3 treatment.
International immunology 1991;3(7):683-90.
1991: M L Joffret; C Zanetti; S Morgeaux; CLAUDE LECLERC; P Sureau; Pierre Perrin
Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 production.
Biologicals : journal of the International Association of Biological Standardization 1991;19(2):113-23.
1991: CLAUDE LECLERC; Edith Deriaud; V Mimic; Sylvie van der Werf
Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1.
Journal of virology 1991;65(2):711-8.
1991: P Martineau; alain charbit; CLAUDE LECLERC; C Werts; D O'Callaghan; Maurice Hofnung
A genetic system to elicit and monitor antipeptide antibodies without peptide synthesis.
Bio/technology (Nature Publishing Company) 1991;9(2):170-2.
1991: J M Clement; alain charbit; P Martineau; D O'Callaghan; S Szmelcman; CLAUDE LECLERC; Maurice Hofnung
Bacterial vectors to target and/or purify polypeptides: their use in immunological studies.
Annales de biologie clinique 1991;49(4):249-54.
1990: G Przewlocki; CLAUDE LECLERC
Role of major and minor histocompatibility antigens in the suppression of alloreactive cytotoxic responses induced by alloantigen pretreatment.
Research in immunology 1990;141(9):839-53.
1990: D O'Callaghan; alain charbit; P Martineau; CLAUDE LECLERC; Sylvie van der Werf; C Nauciel; Maurice Hofnung
Immunogenicity of foreign peptide epitopes expressed in bacterial envelope proteins.
Research in microbiology 1990;141(7-8):963-9.
1990: CLAUDE LECLERC; M P Schutze; Edith Deriaud; G Przewlocki
The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(5):1343-9.
1990: Sylvie van der Werf; alain charbit; CLAUDE LECLERC; V Mimic; J Ronco; M Girard; Maurice Hofnung
Critical role of neighbouring sequences on the immunogenicity of the C3 poliovirus neutralization epitope expressed at the surface of recombinant bacteria.
Vaccine 1990;8(3):269-77.
1990: CLAUDE LECLERC; P Martineau; Sylvie van der Werf; Edith Deriaud; P Duplay; Maurice Hofnung
Induction of virus-neutralizing antibodies by bacteria expressing the C3 poliovirus epitope in the periplasm. The route of immunization influences the isotypic distribution and the biologic activity of the antipoliovirus antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(8):3174-82.
1989: M P Schutze; Pierre Langlade-Demoyen; G Przewlocki; CLAUDE LECLERC
Alloantigen pretreatment induces a down-regulation of the in vivo subsequent development of cytotoxic T lymphocytes directed against linked alloantigens.
European journal of immunology 1989;19(8):1365-71.
1989: CLAUDE LECLERC; alain charbit; A Molla; Maurice Hofnung
Antibody response to a foreign epitope expressed at the surface of recombinant bacteria: importance of the route of immunization.
Vaccine 1989;7(3):242-8.
1989: S Morgeaux; M L Joffret; CLAUDE LECLERC; P Sureau; Pierre Perrin
Evaluation of the induction of specific cytotoxic T lymphocytes following immunization of F1 hybrid mice with rabies antigens.
Research in virology 1989;140(3):193-206.
1989: M P Schutze; Edith Deriaud; G Przewlocki; CLAUDE LECLERC
Carrier-induced epitopic suppression is initiated through clonal dominance.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(8):2635-40.
1989: CLAUDE LECLERC
Suppressor T cells: an appraisal of their role by in vivo elimination.
Research in immunology 1989;140(3):318-23; discussion 339-45.
1989: CLAUDE LECLERC
Vaccination against HIV and SIV.
Current opinion in immunology 1989;2(3):428-32.
1988: Pierre Perrin; M L Joffret; D Oth; CLAUDE LECLERC; P Sureau; L Thibodeau
Interleukin-2 production in vitro: a new approach to the study of rabies vaccine immunogenicity as appraised by testing different glycoprotein presentations.
Vaccine 1988;6(4):331-8.
1988: Pierre Perrin; M L Joffret; CLAUDE LECLERC; D Oth; P Sureau; L Thibodeau
Interleukin 2 increases protection against experimental rabies.
Immunobiology 1988;177(2):199-209.
1988: CLAUDE LECLERC; Edith Deriaud; M P Schutze; L Chedid
Prevention of low dose streptozotocin induced diabetes by muramyl dipeptide.
International journal of immunopharmacology 1988;10(3):293-8.
1987: A Hosmalin; Claude Carelli; J Gaillard; P Lefrancier; Hervé Drobecq; CLAUDE LECLERC; O Amar; F Audibert; L Chedid
Structural requirements for the induction of "immunological castration" by linear monomeric LHRH-lys-MDP administered in saline.
Clinical immunology and immunopathology 1987;45(3):447-60.
1987: M P Schutze; CLAUDE LECLERC; M Jolivet; Edith Deriaud; F Audibert; C C Chang; L Chedid
A potential anti-pregnancy vaccine built by conjugation of the beta-subunit of human chorionic gonadotropin to adjuvant-active muramyl peptide.
American journal of reproductive immunology and microbiology : AJRIM 1987;14(3):84-90.
1987: F R Vogel; CLAUDE LECLERC; M P Schutze; M Jolivet; F Audibert; T W Klein; L Chedid
Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
Cellular immunology 1987;107(1):40-51.
1987: CLAUDE LECLERC; G Przewlocki; M P Schutze; L Chedid
A synthetic vaccine constructed by copolymerization of B and T cell determinants.
European journal of immunology 1987;17(2):269-73.
1987: M P Schutze; CLAUDE LECLERC; F R Vogel; L Chedid
Epitopic suppression in synthetic vaccine models: analysis of the effector mechanisms.
Cellular immunology 1987;104(1):79-90.
1985: M P Schutze; CLAUDE LECLERC; M Jolivet; F Audibert; L Chedid
Carrier-induced epitopic suppression, a major issue for future synthetic vaccines.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(4):2319-22.
1984: CLAUDE LECLERC; F M Audibert; L A Chedid; Edith Deriaud; N K Masihi; E Lederer
Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc.
Infection and immunity 1984;43(3):870-5.